☆ 4.7 Article

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

FRONTIERS IN PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Otorhinolaryngology

Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis

Sebastian F. N. Bode et al.

Summary: This study aims to evaluate subjective and objective sinunasal symptoms after start of CFTR-modulator triple therapy. The results show that highly effective CFTR-modulator therapy has a significant positive impact on both subjective and objective sinunasal symptoms in patients with CF, including children.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)

Add to Collection

Article Respiratory System

Longitudinal Magnetic Resonance Imaging Detects Onset and Progression of Chronic Rhinosinusitis from Infancy to School Age in Cystic Fibrosis

Lena Wucherpfennig et al.

Summary: This study longitudinally evaluated chronic rhinosinusitis (CRS) in children with cystic fibrosis (CF) using paranasal sinus magnetic resonance imaging (MRI). The results showed that CRS starts early in infancy and progresses in severity until school age. The study also found that lumacaftor/ivacaftor therapy can improve CRS in children with CF.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)

Add to Collection

Article Critical Care Medicine

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles

Simon Y. Graeber et al.

Summary: Treatment with ELX/TEZ/IVA leads to effective improvement of CFTR function in airway and intestinal epithelia in patients with CF and one or two F508del alleles.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Respiratory System

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis

Amanda L. Stapleton et al.

Summary: ELX/TEZ/IVA therapy rapidly and durably improves sinonasal disease in individuals with cystic fibrosis, as evidenced by objective measures such as endoscopy and CT findings.

JOURNAL OF CYSTIC FIBROSIS (2022)

Add to Collection

Article Respiratory System

Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaf tor/tezacaf tor/ivacaf tor therapy in adults with cystic fibrosis

Lena Wucherpfennig et al.

Summary: This study found that therapy with Elexacaftor/Tezacaftor/Ivacaftor can improve chest and sinus abnormalities in adult cystic fibrosis patients, indicating the reversibility of structural lung and sinus abnormalities in patients with established disease.

JOURNAL OF CYSTIC FIBROSIS (2022)

Add to Collection

Article Respiratory System

Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status Deep Learning CT Analysis and Patient-reported Outcomes

Daniel M. Beswick et al.

Summary: ETI has substantial improvements in sinus CT opacification and productivity loss, as well as clinically meaningful improvements in sinonasal QOL and health utility. The improvements were rapid, robust, and durable over the study.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)

Add to Collection

Article Respiratory System

Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis

Emily DiMango et al.

Summary: Elexacaftor-tezacaftor-ivacaftor significantly improves sinonasal symptoms in cystic fibrosis patients, with greater benefits observed in those who had previously used CFTR modulators.

JOURNAL OF CYSTIC FIBROSIS (2021)

Add to Collection

Article Critical Care Medicine

Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study

Jordana E. Hoppe et al.

Summary: The study demonstrated that lumacaftor-ivacaftor is generally safe and well tolerated for long-term use in children with cystic fibrosis aged 2-5 years, and treatment effects are maintained over time.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Immunology

Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid

Jochen G. Mainz et al.

Summary: In the field of cystic fibrosis therapy, the approval of CFTR channel modulators is a major breakthrough. However, the current method of measuring the effects of these modulators based on pulmonary function has limitations in detecting early structural damages. A novel method of assessing inflammatory markers through nasal lavage has shown a significant decline in inflammatory mediators in CF patients undergoing CFTR-modulator therapy.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis

Jaehi Chung et al.

Summary: This study found a positive correlation between inflammation and structural abnormalities in MRI in cystic fibrosis patients, with pro-inflammatory markers NE and NE/A1AT complex levels significantly correlating with CRS-MRI sum score. S. aureus infection was associated with increased levels of IL-6 and IL-8, indicating these biomarkers as signs of CRS pathology in CF patients.

ANTIOXIDANTS (2021)

Add to Collection

Article Respiratory System

Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis

Simon Y. Graeber et al.

Summary: This study found that lumacaftor-ivacaftor has beneficial effects on lung ventilation, morphology, perfusion, airway microbiome, and inflammation in CF patients. LCI and MRI may be more sensitive indicators than FEV1% predicted in assessing response to CFTR modulator therapy in patients with chronic CF lung disease.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Add to Collection

Article Critical Care Medicine

Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications

Marcus A. Mall et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Article Respiratory System

Magnetic Resonance Imaging Detects Chronic Rhinosinusitis in Infants and Preschool Children with Cystic Fibrosis

Olaf Sommerburg et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry G. M. Heijerman et al.

LANCET (2019)

Add to Collection

Article Medicine, General & Internal

Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

P. G. Middleton et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Critical Care Medicine

Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS) A Randomized, Double-Blind, Controlled Study

Mirjam Stahl et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Article Critical Care Medicine

Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis

Simon Y. Graeber et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection

Article Critical Care Medicine

Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis

Mirjam Stahl et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Add to Collection

Review Otorhinolaryngology

Endoscopic Management of Paranasal Sinus Mucoceles: Meta-analysis of Visual Outcomes

Leonid M. Zukin et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)

Add to Collection

Article Respiratory System

Optical coherence tomography detects structural abnormalities of the nasal mucosa in patients with cystic fibrosis

Ute Oltmanns et al.

JOURNAL OF CYSTIC FIBROSIS (2016)

Add to Collection

Review Critical Care Medicine

Progress in therapies for cystic fibrosis

Kris De Boeck et al.

LANCET RESPIRATORY MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

C. E. Wainwright et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Multidisciplinary Sciences

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis

Sebastien Boutin et al.

PLOS ONE (2015)

Add to Collection

Article Critical Care Medicine

Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease

Mark O. Wielpuetz et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Add to Collection

Article Respiratory System

Importance of bacteriology in upper airways of patients with Cystic Fibrosis

M. C. Berkhout et al.

JOURNAL OF CYSTIC FIBROSIS (2013)

Add to Collection

Article Respiratory System

CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients

Jacob Rasmussen et al.

JOURNAL OF CYSTIC FIBROSIS (2012)

Add to Collection

Article Respiratory System

Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

J. G. Mainz et al.

THORAX (2009)

Add to Collection

Article Gastroenterology & Hepatology

CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis

S Hirtz et al.

GASTROENTEROLOGY (2004)

Add to Collection

Article Medicine, Research & Experimental

Paranasal sinus development: A radiographic study

RK Shah et al.

LARYNGOSCOPE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.